TLR7 and COVID-19: In an extended sample of 3269 patients with critical COVID-19, we identified 57 patients carrying a rare predicted LOF variant at 14 type I IFN-related influenza susceptibility loci (including TYK2) or with biochemically proven TLR7 deficiency (74).